Astrocyte-conditional knockout of MOB2 inhibits the phenotypic conversion of reactive astrocytes from A1 to A2 following spinal cord injury in mice

  • Int J Biol Macromol. 2025 Apr:300:140289. doi: 10.1016/j.ijbiomac.2025.140289.
Xin Tao  1 Haining Chen  2 Zhenghuan Zhu  3 Tianran Ren  4 Hongming Zhen  4 Xiaoliang Sun  3 Yu Song  4 Xu Xu  4 Zhiwen Song  5 Jinbo Liu  6
Affiliations
  • 1. Department of Spinal Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, People's Republic of China; Department of Orthopedics, The People's Hospital of Liyang, Liyang 213300, Jiangsu, People's Republic of China.
  • 2. Department of Orthopedics, The First Affiliated Hospital of Jiangsu University, Zhenjiang 212000, Jiangsu, People's Republic of China.
  • 3. Department of Orthopedics, Changzhou Maternal and Child Health Care Hospital, Changzhou 213000, Jiangsu, People's Republic of China.
  • 4. Department of Spinal Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, People's Republic of China.
  • 5. Department of Spinal Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, People's Republic of China. Electronic address: [email protected].
  • 6. Department of Spinal Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, People's Republic of China. Electronic address: [email protected].
Abstract

After spinal cord injury (SCI), reactive astrocytes in the injured area are triggered after spinal cord injury (SCI) and to polarize into A1 astrocytes with a proinflammatory phenotype or A2 astrocytes with an anti-inflammatory phenotype. Monopolar spindle binder 2 (MOB2) induces astrocyte stellation, maintains cell homeostasis, and promotes neurite outgrowth; however, its role in the phenotypic transformation of reactive astrocytes remains unclear. Here, we confirmed for the first time that MOB2 is associated with A1/A2 phenotypic switching in reactive astrocytes following SCI in mice. MOB2 modulated A1/A2 transformation in a primary astrocyte reactive cell model. Therefore, we constructed MOB2 conditional knockout mice (MOB2GFAP-CKO) and discovered that conditional knockout of MOB2 inhibited the conversion of reactive astrocytes from A1 to A2 and hindered spinal cord function recovery. Mechanistically, MOB2 increased the activation of PI3K-AKT signaling to promote A1/A2 transformation in vitro, whereas sc79 (an Akt Activator) reversed the subtype transformation of reactive astrocytes and improved functional recovery in MOB2GFAP-CKO mice after SCI. Taken together, study provides the first insights into how MOB2 acts as a novel regulator to promote the conversion this of the reactive astrocyte phenotype from A1 to A2, showing great potential for the treatment of SCI.

Keywords
MOB2; PI3K-AKT signaling; Spinal cord injury.
Products
Inhibitors & Agonists
Other Products